The EBITDA margin stood at 33% in the reporting quarter compared to 32.7% a year ago. Shares of Caplin Point Laboratories Ltd ...
The company's revenue from operations increased to Rs 3,374 crore in Q3 FY25, a marginal 1.5 per cent Y-o-Y rise from Rs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback